Spots Global Cancer Trial Database for ak112
Every month we try and update this database with for ak112 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| AK112 in Advanced Non-Small Cell Lung Cancer | NCT05499390 | Advanced Non-sm... | AK112 Pembrolizumab | 18 Years - | Akeso | |
| Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors | NCT05689853 | Solid Tumor, Ad... | AK119 AK112 | 18 Years - 75 Years | Akeso | |
| A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer | NCT05227664 | Metastatic Trip... Locally Advance... | AK117 AK112 Nab paclitaxel paclitaxel | 18 Years - 75 Years | Akeso | |
| AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer | NCT05904379 | Advanced Non-sm... | AK112 AK104 Carboplatin paclitaxel pemetrexed Docetaxel | 18 Years - 75 Years | Akeso | |
| A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC | NCT04736823 | NSCLC | AK112 Pemetrexed Paclitaxel Carboplatin Docetaxel | 18 Years - 75 Years | Akeso | |
| Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients | NCT05846867 | Colorectal Canc... | AK119 AK112 Oxaliplatin Irinotecan Calcium folinat... Fluorouracil | 18 Years - | Akeso | |
| Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients | NCT05846867 | Colorectal Canc... | AK119 AK112 Oxaliplatin Irinotecan Calcium folinat... Fluorouracil | 18 Years - | Akeso | |
| AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC | NCT05247684 | Resectable Non-... | AK112 Carboplatin Cisplatin Paclitaxel | 18 Years - 75 Years | Akeso | |
| A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma | NCT06424626 | Melanoma Mucosal Melanom... Metastatic Mela... | AK104+Axitinib AK112+Axitinib | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients | NCT05846867 | Colorectal Canc... | AK119 AK112 Oxaliplatin Irinotecan Calcium folinat... Fluorouracil | 18 Years - | Akeso | |
| A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer | NCT05382442 | Metastatic Colo... | AK112 AK117 Oxaliplatin Capecitabine Irinotecan Leucovorin 5-fluorouracil | 18 Years - 75 Years | Akeso | |
| A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | NCT05229497 | Advanced Malign... | AK112 AK117 Carboplatin Cisplatin 5-Fluorouracil | 18 Years - 75 Years | Akeso | |
| A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer | NCT05227664 | Metastatic Trip... Locally Advance... | AK117 AK112 Nab paclitaxel paclitaxel | 18 Years - 75 Years | Akeso | |
| Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC | NCT05116007 | SCLC, Extensive... | AK112 Etoposide Carboplatin | 18 Years - 75 Years | Akeso | |
| A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC) | NCT05432492 | Hepatocellular ... | AK112 | 18 Years - 75 Years | Akeso | |
| AK112 in Advanced Non-Small Cell Lung Cancer | NCT05499390 | Advanced Non-sm... | AK112 Pembrolizumab | 18 Years - | Akeso | |
| A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors | NCT04597541 | Solid Tumor, Ad... | AK112 | 18 Years - 75 Years | Akeso | |
| A Study of AK112 in Advanced Malignant Tumors | NCT05214482 | Advanced Malign... | AK112 AK117 Chemotherapy | 18 Years - 75 Years | Akeso | |
| A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | NCT05229497 | Advanced Malign... | AK112 AK117 Carboplatin Cisplatin 5-Fluorouracil | 18 Years - 75 Years | Akeso | |
| Study of AK112 in the Treatment of Advanced Gynecological Tumors | NCT04870177 | Gynecologic Can... Cancer Metastat... Ovarian Neoplas... Cervical Neopla... Endometrial Neo... | AK112 | 18 Years - 75 Years | Akeso | |
| A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC | NCT04736823 | NSCLC | AK112 Pemetrexed Paclitaxel Carboplatin Docetaxel | 18 Years - 75 Years | Akeso | |
| Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients | NCT05636267 | NSCLC | AK119 AK112 Pemetrexed Carboplatin | 18 Years - 75 Years | Akeso |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
